Clemondo Group (CLEM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for Q2 2024 were 66.8 MSEK, down 9% year-over-year, with declines concentrated in the Vehicle segment, while Hygiene and Industry segments grew despite a weak economy.
EBITDA was 5.5 MSEK (8.2% margin), EBIT 1.8 MSEK (2.7% margin), and net income 0.9 MSEK; cost control and efficiency measures improved gross margin to 38.5%.
Financial position strengthened, with equity ratio at 62.3% and net debt reduced to 16.8 MSEK.
Renewed a key contract with Lyreco Sverige worth 16–20 MSEK over two years.
Financial highlights
Net sales Q2 2024: 66.8 MSEK (73.5 MSEK Q2 2023); H1 2024: 134.1 MSEK (152.2 MSEK H1 2023).
EBITDA Q2 2024: 5.5 MSEK (7.9 MSEK); EBIT: 1.8 MSEK (4.0 MSEK); net income: 0.9 MSEK (1.8 MSEK).
Gross margin improved to 38.5% (36.9% Q2 2023).
Cash flow from operations after working capital changes: 5.1 MSEK (2.5 MSEK).
Equity ratio: 62.3% (52.5%); net debt: 16.8 MSEK (51.2 MSEK Q2 2023).
Outlook and guidance
Management expects gradual improvement, with cost and efficiency measures showing effect and two of three segments growing.
Continued optimism for Hygiene and Industry, with Vehicle segment showing early signs of stabilization.
Latest events from Clemondo Group
- Q4 2025 saw 11% sales growth, margin pressure from investments, and strong Medical Care gains.CLEM
Q4 202526 Feb 2026 - Q3 2025 saw 13% sales growth and strong segment performance, but lower margins due to investments.CLEM
Q3 202511 Nov 2025 - Net sales rose 9% year-over-year, with strong growth in Medical Care and Industrial segments.CLEM
Q2 202520 Aug 2025 - Q3 2024 saw stable earnings, strong equity, and growth in Hygien and Industri amid a weak market.CLEM
Q3 202413 Jun 2025 - Q1 2025 saw 12% sales growth, margin expansion, and Medical Care emerge as a key growth driver.CLEM
Q1 20256 Jun 2025 - Hygiene and Industry growth offset Vehicle weakness, with strong equity and new contracts for 2025.CLEM
Q4 20245 Jun 2025